| Overview
Gene expression profiling methods enable the quantification of multiple transcripts in a single RNA sample. Relatively new and continually evolving methods, such as microarray
analysis, multiplex PCR and quantitative real-time RT-PCR, are integral to deciphering the molecular mechanisms involved in development and disease, and are important tools in
the identification of new drug targets.
The Gene Expression Profiling Dashboard™ was developed from responses to a 36-question survey completed by 367 scientists predominantly located in North America and Europe.
This Dashboard reveals key market indicators for the gene expression profiling market as a whole as well as for the following methods representing market sub-segments:
• Microarray-based gene expression studies
• Serial Analysis of Gene Expression (SAGE) studies
• Differential gene expression studies using multiplex PCR
• qRT-PCR (cDNA template) using gene specific fluorescent probe
• qRT-PCR (cDNA template) using non-specific SYBR Green
• Northern blot analysis
In order to dive more deeply into the characteristics and dynamics of the market for gene expression profiling products, Percepta has introduced the Gene Expression Profiling Dashboard™,
designed to take a snapshot of the current market landscape with the future goal of repeating and publishing the study to give Dashboard readers the ongoing story of how the market
is adapting to new products, new competitors and new sales and marketing strategies.
Survey Methodology
In November/December of 2006, Percepta fielded three surveys to our panel of active life scientists:
• Gene Silencing and Gene Expression Profiling Survey
• Nucleic Acid Purification and Amplification Survey
• Mammalian Transfection and Cell Culture Survey
This report reveals the results of the Gene Expression Profiling section of the Gene Silencing and Gene Expression Profiling Survey. The results of the Gene Silencing portion of
the survey as well as the other two studies are available as separate Life Science Dashboard™ publications. Contact Percepta for more information on these additional reports.
Individuals were invited by e-mail blast to click through to a webpage at bioanalytix.com where the survey was hosted. Invitations were delivered on November 13, 2006 and results
collected through December 8. A total of 367 scientists completed the survey, of which 232 are actively engaged in performing gene expression profiling experiments.
Respondent Demographics
Respondents from the academic, government and commercial market segments are well represented, with approximately 18% of respondents employed in an industry setting. About 78%
of respondents are from North America, while 18% reside in Europe.
Junior (Lab Tech, Grad Students), mid level (Post-Doc, Lab Manager) and senior (Professor/PI, Group Leader) scientists are well represented in the data set, with the most cited
job titles being Scientist/Senior Scientist (21.3% of respondents) and Post-Doctoral Fellow (19.1%).
A wide variety of scientific areas of specialization is also evident, led by cell biology (named by 17.3% of respondents as their primary area of expertise) and biochemistry (named
by 16.2% of respondents). Immunology (8.5%), microbiology/ infectious disease/ virology (7.9%) and genomics (7.9%) are the only other applications named by more than 5% of respondents.
Small (1-5 scientists), medium (6-20 scientists) and large (>20 scientists) laboratories are well represented: 32.3% of respondents work in labs where 1 to 5 people perform
experiments; 52.7% in labs with 6 to 20 experimenters, and the remaining 15.0% in labs with greater than 20 bench scientists.
|